Citrus Sinensis ID: 041114


Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------660-------670-------680
MCTIFQITCDDAFFNRCLDCFLGKAACTRNLQDNVAALAIELAKLIAAKNNLITRVLDAERQQLRRLDQVQVWLSRVEAVKTETDELIRRSSKEIDKLCPRAYCSKSCKSSYKFRKQVAKKLRDVRTLIGEGVFEVVAERPPQPVADEIPTEQIVEGLQSQLKQVWRCLVEESIGIIGLYGMGSVEKVGEETLDSHHDILELAQTVTKECGGSPLALITIGRAMAYKKKPEEWRYAIEVLRKSSSSEFAGLVKEVYPLLKFSYDSLQNDVIRSCFLYCCLYPEDFAILKRDLIDCWIGEGFLDERDSFSAQNQGYYIVGTLVHAWLLEEVGDDKVKLHGVLHDMALWISCEIEEEKENFLVCAGRGLKEAPEVKEWETVRRLSLMQNQIKILSEAPTCPHLHYEFKMITDGFFQFMPLLKVLNMSRETNIKELLGELKALVNLKCVNLEWARDLVTIPLEVISNFSKLRVLRLFGTVLAKELLGLKHLEELDFTLRCVHSLQILVSSNKLQSCTRALVLIRFKDSKSIDVIALARLKHLSTLHFSKCEELEEWKTDYTSGTVLKSPQPFVFCSLHKVTITFCPKLKGLTFLVFAPNLKCLSLFDCTAMEEIISAGKFVHTPEMMGNTMDPCAKLRKLPLDSNSALEHKIAIRGEAGWWGCLQWENEATQIAFLPCFKTIY
cccEEEEccHHHHHHHHHHHHcccccEEccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHHHHHccccEEEEEcccccccccccccHHHHHcccccccHHHHcccccccccccccccccccccccccccccccHHHHHHHHHHHccccHHHHHHHHHHHcccccHHHHHHHHHHHHHccccccccccccccccHHccccccccccHHHHHHHHccccccccccHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHcccccEEcccccccccHHHHHHHHHHHHHHcccccEEEEccccccccccccccccEEEEEEEcccccccccccccccccccccccccHHHcccccccEEEcccccccccccHHHcccccccEEccccccccccccHHHHcccccccEEEEccccccccccccccccccEEEEcccccccccccccccccccccEEEEEEccccccccccccccccccEEEEEEccccccEEcccccccccccccccccccccEEEEEccccccccccccccccccEEEEEccccccccccccccccccccEEcccccccccccccccccccccccEEEEccccccccccccccccccccccccEEcc
cccEEEEEccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccHHHHHHHcccccccccHHHHHHcHEHHEEHHHHHHHHHccccEEEEEcccccEEEEEccccEEEEccccHHHHHHHcHHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHcccHHHHHHHHHHHHccccHHHHHHHHHHHHcccHHccccccccccHHHEEcccccccHHHHHHHHHHHcccccccccHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHHHHccccccEEEEHHHHHHHHHHHHHHHccccccEEEEcccccEcccccccHHHEEEEEcccccHHccccccccHHHHHHHHHccHHHHHcccccEEEEccccccHcccccHHcccccccEEEcccccccccccHHHHcccccccEEEEccccccccccccccccEEEEEEcccccHcccccccccccccEEEEEccccccccccHHcccccccccEEEEEccccHccccccccccHHHHcccccccccccEEEEEcccccccccHccccccccEEEEcccccHccccccccccccccccEEEEcccccccEccccccccHcccEEEcccHHHHHcccccHHHHHHHccccHHccc
mctifqitcddaffNRCLDCFLGKAACTRNLQDNVAALAIELAKLIAAKNNLITRVLDAERQQLRRLDQVQVWLSRVEAVKTETDELIRRSSKEidklcpraycskscksSYKFRKQVAKKLRDVRTLIGEGVFEvvaerppqpvadeiptEQIVEGLQSQLKQVWRCLVEESIGIIGlygmgsvekvgeetLDSHHDILELAQTVTkecggsplaLITIGRAMAYKKKPEEWRYAIEVLRKSSSSEFAGLVKEVYPLLKFSYDSLQNDVIRSCFLYCCLYPEDFAILKRDLIdcwigegflderdsfsaqnqgYYIVGTLVHAWLLEevgddkvkLHGVLHDMALWISCEIEEEKENFLVCAgrglkeapevkeWETVRRLSLMQNQIKIlseaptcphlhyefkmitdgffqfmPLLKVLNMSRETNIKELLGELKALVNLKCVNLEWARDLVTIPLEVISNFSKLRVLRLFGTVLAKELLGLKHLEELDFTLRCVHSLQILVSSNKLQSCTRALVLirfkdsksIDVIALARLKHlstlhfskceeleewktdytsgtvlkspqpfvfcslhkvtitfcpklkgltflvfapnlkclslfdCTAMEEIISagkfvhtpemmgntmdpcaklrklpldsnsalEHKIAIRGEAGWWGCLQWENEatqiaflpcfktiy
MCTIFQITCDDAFFNRCLDCFLGKAACTRNLQDNVAALAIELAKLIAAKNNLITRVLDAERQQLrrldqvqvwlsrveavktetdelirrsskeidklcpraycsksckssykfRKQVAKKLRDVRTLIGegvfevvaerppqpvadEIPTEQIVEGLQSQLKQVWRCLVEESIGIIGLYGMGSVEKVGEETLDSHHDILELAQTVTKECGGSPLALITIGRAMAYKKKPEEWRYAIEVlrkssssefaGLVKEVYPLLKFSYDSLQNDVIRSCFLYCCLYPEDFAILKRDLIDCWIGEGFLDERDSFSAQNQGYYIVGTLVHAWLLEEVGDDKVKLHGVLHDMALWISCEIEEEKENFLVCAGRglkeapevkewetVRRLSLMQNQIKILSEAPTCPHLHYEFKMITDGFFQFMPLLKVLNMSRETNIKELLGELKALVNLKCVNLEWARDLVTIPLEVISNFSKLRVLRLFGTVLAKELLGLKHLEELDFTLRCVHSLQIlvssnklqscTRALVLirfkdsksiDVIALARLKHlstlhfskceELEEWKTDYTSGTVLKSPQPFVFCSLHKVTITFCPKLKGLTFLVFAPNLKCLSLFDCTAMEEIISAgkfvhtpemMGNTMDPCAKLRKLPLDSNSALEHKIAIRGEAGWWGCLQWENEATQIAFLPCFKTIY
MCTIFQITCDDAFFNRCLDCFLGKAACTRNLQDNVaalaielakliaakNNLITRVLDAErqqlrrldqvqvWLSRVEAVKTETDELIRRSSKEIDKLCPRAycsksckssykFRKQVAKKLRDVRTLIGEGVFEVVAERPPQPVADEIPTEQIVEGLQSQLKQVWRCLVEESIGIIGLYGMGSVEKVGEETLDSHHDILELAQTVTKECGGSPLALITIGRAMAYKKKPEEWRYAIEVLRKSSSSEFAGLVKEVYPLLKFSYDSLQNDVIRSCFLYCCLYPEDFAILKRDLIDCWIGEGFLDERDSFSAQNQGYYIVGTLVHAWLLEEVGDDKVKLHGVLHDMALWISCEIEEEKENFLVCAGRGLKEAPEVKEWETVRRLSLMQNQIKILSEAPTCPHLHYEFKMITDGFFQFMPLLKVLNMSRETNIKELLGELKALVNLKCVNLEWARDLVTIPLEVISNFSKLRVLRLFGTVlakellglkhleelDFTLRCVHSLQILVSSNKLQSCTRALVLIRFKDSKSIDVIALARLKHLSTLHFSKCEELEEWKTDYTSGTVLKSPQPFVFCSLHKVTITFCPKLKGLTFLVFAPNLKCLSLFDCTAMEEIISAGKFVHTPEMMGNTMDPCAKLRKLPLDSNSALEHKIAIRGEAGWWGCLQWENEATQIAFLPCFKTIY
*CTIFQITCDDAFFNRCLDCFLGKAACTRNLQDNVAALAIELAKLIAAKNNLITRVLDAERQQLRRLDQVQVWLSRVEAVKTETDELIRRSSKEIDKLCPRAYCSKSCKSSYKFRKQVAKKLRDVRTLIGEGVFEVVAE*********IPTEQIVEGLQSQLKQVWRCLVEESIGIIGLYGMGSVEKVGEETLDSHHDILELAQTVTKECGGSPLALITIGRAMAYKKKPEEWRYAIEVLRKSSSSEFAGLVKEVYPLLKFSYDSLQNDVIRSCFLYCCLYPEDFAILKRDLIDCWIGEGFLDERDSFSAQNQGYYIVGTLVHAWLLEEVGDDKVKLHGVLHDMALWISCEIEEEKENFLVCAGRGLKEAPEVKEWETVRRLSLMQNQIKILSEAPTCPHLHYEFKMITDGFFQFMPLLKVLNMSRETNIKELLGELKALVNLKCVNLEWARDLVTIPLEVISNFSKLRVLRLFGTVLAKELLGLKHLEELDFTLRCVHSLQILVSSNKLQSCTRALVLIRFKDSKSIDVIALARLKHLSTLHFSKCEELEEWKTDYTSGTVLKSPQPFVFCSLHKVTITFCPKLKGLTFLVFAPNLKCLSLFDCTAMEEIISAGKFVHTPEMMGNTMDPCAKLRKLPLDSNSALEHKIAIRGEAGWWGCLQWENEATQIAFLPCFKTI*
***IFQITCDDAFFNRCLDCFLGKAACTRNLQDNVAALAIELAKLIAAKNNLIT*************DQVQVWLSRVEAVKTETDELIRRSSKEIDKLCPRAYCSKSCKSSYKFRKQVAKKLRDVRTLIGEGVFEVVAERPPQPVADEIP*********S****VWRCLVEESIGIIGLYGMGSVEKVGEETLDSHHDILELAQTVTKECGGSPLALITIGRAMAYKKKPEEWRYAIEVLRKSS*****G**KEVYPLLKFSYDSLQNDVIRSCFLYCCLYPEDFAILKRDLIDCWIGEGFLDERDSFSAQNQGYYIVGTLVHAWLLEEVGDDKVKLHGVLHDMALWISCEIEEEKENFLVCAGRGLKEAPEVKEWETVRRLSLMQNQIKILSEAPTCPHLHYEFKMITDGFFQFMPLLKVLNMSRETNIKELLGELKALVNLKCVNLEWARDLVTIPLEVISNFSKLRVLRLFGTVLAKELLGLKHLEELDFTLRCVHS***************ALVLIRFKDSKS****ALARLKHLSTLHFSKCEELEEWKTDYTSGTVLKSPQPFVFCSLHKVTITFCPKLKGLTFLVFAPNLKCLSLFDCTAMEEIISAGKFVHTPEMMGNTMDPCAKLRKLPLDSN**L****AIRGEAGWWGCLQWENEATQIAFLPCFKTIY
MCTIFQITCDDAFFNRCLDCFLGKAACTRNLQDNVAALAIELAKLIAAKNNLITRVLDAERQQLRRLDQVQVWLSRVEAVKTETDELIRRSSKEIDKLCPRAYCSKSCKSSYKFRKQVAKKLRDVRTLIGEGVFEVVAERPPQPVADEIPTEQIVEGLQSQLKQVWRCLVEESIGIIGLYGMGSVEKVGEETLDSHHDILELAQTVTKECGGSPLALITIGRAMAYKKKPEEWRYAIEVLRKSSSSEFAGLVKEVYPLLKFSYDSLQNDVIRSCFLYCCLYPEDFAILKRDLIDCWIGEGFLDERDSFSAQNQGYYIVGTLVHAWLLEEVGDDKVKLHGVLHDMALWISCEIEEEKENFLVCAGRGLKEAPEVKEWETVRRLSLMQNQIKILSEAPTCPHLHYEFKMITDGFFQFMPLLKVLNMSRETNIKELLGELKALVNLKCVNLEWARDLVTIPLEVISNFSKLRVLRLFGTVLAKELLGLKHLEELDFTLRCVHSLQILVSSNKLQSCTRALVLIRFKDSKSIDVIALARLKHLSTLHFSKCEELEEWKTDYTSGTVLKSPQPFVFCSLHKVTITFCPKLKGLTFLVFAPNLKCLSLFDCTAMEEIISAGKFVHTPEMMGNTMDPCAKLRKLPLDSNSALEHKIAIRGEAGWWGCLQWENEATQIAFLPCFKTIY
*CTIFQITCDDAFFNRCLDCFLGKAACTRNLQDNVAALAIELAKLIAAKNNLITRVLDAERQQLRRLDQVQVWLSRVEAVKTETDELIRRSSKEIDKLCPRAYCSKSCKSSYKFRKQVAKKLRDVRTLIGEGVFEVVAERPPQPVADEIPTEQIVEGLQSQLKQVWRCLVEESIGIIGLYGMGSVEKVGEETLDSHHDILELAQTVTKECGGSPLALITIGRAMAYKKKPEEWRYAIEVLRKSSSSEFAGLVKEVYPLLKFSYDSLQNDVIRSCFLYCCLYPEDFAILKRDLIDCWIGEGFLDERDSFSAQNQGYYIVGTLVHAWLLEEVGDDKVKLHGVLHDMALWISCEIEEEKENFLVCAGRGLKEAPEVKEWETVRRLSLMQNQIKILSEAPTCPHLHYEFKMITDGFFQFMPLLKVLNMSRETNIKELLGELKALVNLKCVNLEWARDLVTIPLEVISNFSKLRVLRLFGTVLAKELLGLKHLEELDFTLRCVHSLQILVSSNKLQSCTRALVLIRFKDSKSIDVIALARLKHLSTLHFSKCEELEEWKTDYTSGTVLKSPQPFVFCSLHKVTITFCPKLKGLTFLVFAPNLKCLSLFDCTAMEEIISAGKFVHTPEMMGNTMDPCAKLRKLPLDSNSALEHKIAIRGEAGWWGCLQWENEATQIAFLPCFKTIY
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MCTIFQITCDDAFFNRCLDCFLGKAACTRNLQDNVAALAIExxxxxxxxxxxxxxxxxxxxxQLRRLDQVQVWLSRVEAVKTETDELIRRSSKEIDKLCPRAYCSKSCKSSYKFRKQVAKKLRDVRTLIGEGVFEVVAERPPQPVADEIPTEQIVEGLQSQLKQVWRCLVEESIGIIGLYGMGSVEKVGEETLDSHHDILELAQTVTKECGGSPLALITIGRAMAYKKKPEEWRYAIEVLRKSSSSEFAGLVKEVYPLLKFSYDSLQNDVIRSCFLYCCLYPEDFAILKRDLIDCWIGEGFLDERDSFSAQNQGYYIVGTLVHAWLLEEVGDDKVKLHGVLHDMALWISCEIEEEKENFLVCAGRGLKEAPEVKEWETVRRLSLMQNQIKILSEAPTCPHLHYEFKMITDGFFQFMPLLKVLNMSRETNIKELLGELKALVNLKCVNLEWARDLVTIPLEVISNFSKLRVLRLFGTVLAKELLGLKHLEELDFTLRCVHSLQILVSSNKLQSCTRALVLIRFKDSKSIDVIALARLKHLSTLHFSKCEELEEWKTDYTSGTVLKSPQPFVFCSLHKVTITFCPKLKGLTFLVFAPNLKCLSLFDCTAMEEIISAGKFVHTPEMMGNTMDPCAKLRKLPLDSNSALEHKIAIRGEAGWWGCLQWENEATQIAFLPCFKTIY
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query680 2.2.26 [Sep-21-2011]
Q8RXS5888 Probable disease resistan yes no 0.719 0.550 0.355 6e-84
O64973889 Disease resistance protei no no 0.713 0.545 0.368 1e-79
P60838894 Probable disease resistan no no 0.711 0.541 0.357 8e-77
O82484892 Putative disease resistan no no 0.704 0.536 0.347 4e-71
Q8L3R3885 Disease resistance protei no no 0.702 0.540 0.352 9e-70
Q9SH22884 Probable disease resistan no no 0.705 0.542 0.355 5e-69
P60839884 Probable disease resistan no no 0.714 0.549 0.333 2e-68
Q9SI85893 Probable disease resistan no no 0.701 0.534 0.353 2e-68
Q9LVT3948 Probable disease resistan no no 0.682 0.489 0.326 7e-65
Q9C8T9898 Putative disease resistan no no 0.7 0.530 0.343 9e-65
>sp|Q8RXS5|DRL40_ARATH Probable disease resistance protein At5g63020 OS=Arabidopsis thaliana GN=At5g63020 PE=2 SV=2 Back     alignment and function desciption
 Score =  312 bits (799), Expect = 6e-84,   Method: Compositional matrix adjust.
 Identities = 198/557 (35%), Positives = 309/557 (55%), Gaps = 68/557 (12%)

Query: 186 EKVGEETLDSHHDILELAQTVTKECGGSPLALITIGRAMAYKKKPEEWRYAIEVLRKSSS 245
           +KVGE TL SH +I  +A+TV K+C G PLAL  IG  MAYK+  +EWR AI+VL  SS+
Sbjct: 322 KKVGEITLGSHPEIPTVARTVAKKCRGLPLALNVIGETMAYKRTVQEWRSAIDVL-TSSA 380

Query: 246 SEFAGLVKEVYPLLKFSYDSLQNDVIRSCFLYCCLYPEDFAILKRDLIDCWIGEGFLDER 305
           +EF+G+  E+ P+LK+SYD+L+++ ++ CF YC L+PED  I K DL+D WIGEGF+D R
Sbjct: 381 AEFSGMEDEILPILKYSYDNLKSEQLKLCFQYCALFPEDHNIEKNDLVDYWIGEGFID-R 439

Query: 306 DSFSAQNQGYYIVGTLVHAWLLEEVGDDKVKLHGVLHDMALWISCEIEEEKENFLVCAGR 365
           +   A+NQGY I+G LV + LL E   + VK+H V+ +MALWI+ +  ++KENF+V AG 
Sbjct: 440 NKGKAENQGYEIIGILVRSCLLMEENQETVKMHDVVREMALWIASDFGKQKENFIVQAGL 499

Query: 366 GLKEAPEVKEWETVRRLSLMQNQIKILSEAPTCPHL------HYEFKMITDGFFQFMPLL 419
             +  PE+++W+  RR+SLM N I+ + +AP  P L            I+  FF+ MP+L
Sbjct: 500 QSRNIPEIEKWKVARRVSLMFNNIESIRDAPESPQLITLLLRKNFLGHISSSFFRLMPML 559

Query: 420 KVLNMSRETNIKELLGELKALVNLKCVNLE------WA------RDLVTIPLEV------ 461
            VL++S   +++ L  E+   V+L+ ++L       W       R L+ + LE       
Sbjct: 560 VVLDLSMNRDLRHLPNEISECVSLQYLSLSRTRIRIWPAGLVELRKLLYLNLEYTRMVES 619

Query: 462 ---ISNFSKLRVLRLFGTVLAKE------LLGLKHLEELDFTLRCVHSLQILVSSNKLQS 512
              IS  + L+VLRLF +   ++      L  L++L+ L  TL     L+  +S+ +L S
Sbjct: 620 ICGISGLTSLKVLRLFVSGFPEDPCVLNELQLLENLQTLTITLGLASILEQFLSNQRLAS 679

Query: 513 CTRALVLIRFKDSKSIDVIALARLKHLSTLHFSKCE--ELEEWKTDYTSGTVLKSPQPFV 570
           CTRAL +       S+ +  +A +  L  LHF+  +  E++  + +      + +   F 
Sbjct: 680 CTRALRIENLNPQSSV-ISFVATMDSLQELHFADSDIWEIKVKRNETVLPLHIPTTTTF- 737

Query: 571 FCSLHKVTITFCPKLKGLTFLVFAPNLKCLSLFDCTAMEEIISAGK-------------- 616
           F +L +V++ FC +L+ LT+L+FAPNL  L +   + ++E+I+  K              
Sbjct: 738 FPNLSQVSLEFCTRLRDLTWLIFAPNLTVLRVISASDLKEVINKEKAEQQNLIPFQELKE 797

Query: 617 ----------FVHT-----PEMMGNTMDPCAKLRKLPLDSNSALEHKIAIRGEAGWWGCL 661
                      +H      P +    ++ C++LRKLPL+  S     + I     W   L
Sbjct: 798 LRLENVQMLKHIHRGPLPFPCLQKILVNGCSELRKLPLNFTSVPRGDLVIEAHKKWIEIL 857

Query: 662 QWENEATQIAFLPCFKT 678
           +WE+EAT+  FLP  K 
Sbjct: 858 EWEDEATKARFLPTLKA 874




Probable disease resistance protein.
Arabidopsis thaliana (taxid: 3702)
>sp|O64973|RPS5_ARATH Disease resistance protein RPS5 OS=Arabidopsis thaliana GN=RPS5 PE=1 SV=2 Back     alignment and function description
>sp|P60838|DRL1_ARATH Probable disease resistance protein At1g12280 OS=Arabidopsis thaliana GN=At1g12280 PE=3 SV=1 Back     alignment and function description
>sp|O82484|DRL23_ARATH Putative disease resistance protein At4g10780 OS=Arabidopsis thaliana GN=At4g10780 PE=2 SV=1 Back     alignment and function description
>sp|Q8L3R3|RFL1_ARATH Disease resistance protein RFL1 OS=Arabidopsis thaliana GN=RFL1 PE=3 SV=2 Back     alignment and function description
>sp|Q9SH22|DRL20_ARATH Probable disease resistance protein At1g63360 OS=Arabidopsis thaliana GN=At1g63360 PE=2 SV=1 Back     alignment and function description
>sp|P60839|DRL2_ARATH Probable disease resistance protein At1g12290 OS=Arabidopsis thaliana GN=At1g12290 PE=2 SV=1 Back     alignment and function description
>sp|Q9SI85|DRL14_ARATH Probable disease resistance protein At1g62630 OS=Arabidopsis thaliana GN=At1g62630 PE=3 SV=2 Back     alignment and function description
>sp|Q9LVT3|DRL38_ARATH Probable disease resistance protein At5g47260 OS=Arabidopsis thaliana GN=At5g47260 PE=3 SV=2 Back     alignment and function description
>sp|Q9C8T9|DRL19_ARATH Putative disease resistance protein At1g63350 OS=Arabidopsis thaliana GN=At1g63350 PE=2 SV=1 Back     alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST ?

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query680
24461863 889 NBS-LRR type disease resistance protein 0.714 0.546 0.554 1e-157
24461866 890 NBS-LRR type disease resistance protein 0.714 0.546 0.540 1e-155
24461865 892 NBS-LRR type disease resistance protein 0.716 0.545 0.527 1e-153
24461861 890 NBS-LRR type disease resistance protein 0.717 0.548 0.528 1e-148
24461864 899 NBS-LRR type disease resistance protein 0.711 0.538 0.483 1e-132
15080718479 putative disease resistance gene protein 0.545 0.774 0.555 1e-114
225442867 893 PREDICTED: probable disease resistance p 0.722 0.549 0.441 1e-111
359482672 905 PREDICTED: probable disease resistance p 0.717 0.539 0.431 1e-109
225443158 903 PREDICTED: probable disease resistance p 0.717 0.540 0.420 1e-109
147852651 882 hypothetical protein VITISV_017542 [Viti 0.691 0.532 0.419 1e-105
>gi|24461863|gb|AAN62350.1|AF506028_17 NBS-LRR type disease resistance protein [Citrus trifoliata] Back     alignment and taxonomy information
 Score =  561 bits (1447), Expect = e-157,   Method: Compositional matrix adjust.
 Identities = 320/577 (55%), Positives = 370/577 (64%), Gaps = 91/577 (15%)

Query: 186 EKVGEETLDSHHDILELAQTVTKECGGSPLALITIGRAMAYKKKPEEWRYAIEVLRKSSS 245
           + VGEETL S HDI ELAQ V +ECGG PLALITIG+AMAYKK  EEWR+AIEVLR+S+S
Sbjct: 316 QNVGEETLTSDHDIAELAQIVAEECGGLPLALITIGQAMAYKKTVEEWRHAIEVLRRSAS 375

Query: 246 SEFAGLVKEVYPLLKFSYDSLQNDVIRSCFLYCCLYPEDFAILKRDLIDCWIGEGFLDER 305
            EF G    V  + KFSYDSL +D  RSCFLYCCLYP+D+ ILK DLIDCWIGEGFL+E 
Sbjct: 376 -EFPGF-DNVLRVFKFSYDSLPDDTTRSCFLYCCLYPKDYGILKWDLIDCWIGEGFLEES 433

Query: 306 DSFSAQNQGYYIVGTLVHAWLLEEVGDDKVKLHGVLHDMALWISCEIEEEKENFLVCAGR 365
             F A+NQGY IVGTLV A LLEE+ DDKVK+H V+  MALWI CEIEEEK NFLV AG 
Sbjct: 434 ARFVAENQGYCIVGTLVDACLLEEIEDDKVKMHDVVRYMALWIVCEIEEEKRNFLVRAGA 493

Query: 366 GLKEAPEVKEWETVRRLSLMQNQIKILSEAPTCPHLHYEF-------KMITDGFFQFMPL 418
           GL++AP VKEWE VRRLSLMQN IKILSE PTCP LH  F       + ITDGFF+FMP 
Sbjct: 494 GLEQAPAVKEWENVRRLSLMQNDIKILSEVPTCPDLHTLFLASNNNLQRITDGFFKFMPS 553

Query: 419 LKVLNMSR-------------------------ETNIKELLGELKALVNLKCVNLEWARD 453
           LKVL MS                          +T+I EL  ELK LVNLKC+NL WA  
Sbjct: 554 LKVLKMSHCGDLKVLKLPLGMSMLGSLELLDISQTSIGELPEELKLLVNLKCLNLRWATW 613

Query: 454 LVTIPLEVISNFSKLRVLRLF------------------GTVLAKELLGLKHLEELDFTL 495
           L  IP ++ISN S+L VLR+F                  G VL +ELLGLK+LE L+ TL
Sbjct: 614 LSKIPRQLISNSSRLHVLRMFATGCSHSEASEDSVLFGGGEVLIQELLGLKYLEVLELTL 673

Query: 496 RCVHSLQILVSSNKLQSCTRALVLIRFKDSKS-IDVIALARLKHLSTLHFSKCEELEEWK 554
           R  H+LQ+  SSNKL+SC R+L+L   + +KS ID  A A L HL+ L      E+EE K
Sbjct: 674 RSSHALQLFFSSNKLKSCIRSLLLDEVRGTKSIIDATAFADLNHLNELRIDSVAEVEELK 733

Query: 555 TDYTSGTVLKSPQPFVFCSLHKVTITFCPKLKGLTFLVFAPNLKCLSLFDCTAMEEIISA 614
            DYT   V K  +PFVF SLH+VT+  C KLK LTFLVFAPNLK L L +C AMEEIIS 
Sbjct: 734 IDYTE-IVRKRREPFVFGSLHRVTLGQCLKLKDLTFLVFAPNLKSLQLLNCRAMEEIISV 792

Query: 615 GKFVHTPEMMGNT----------------------------------MDPCAKLRKLPLD 640
           GKF   PE+MG+                                   +  C +L+KLPLD
Sbjct: 793 GKFAEVPEVMGHISPFENLQRLHLFDLPRLKSIYWKPLPFTHLKEMRVHGCNQLKKLPLD 852

Query: 641 SNSALEHKIAIRGEAGWWGCLQWENEATQIAFLPCFK 677
           SNSA   K  IRGEA  W  LQWE++ATQIAF  CF+
Sbjct: 853 SNSA---KFVIRGEAEGWNRLQWEDDATQIAFRSCFQ 886




Source: Citrus trifoliata

Species: Citrus trifoliata

Genus: Citrus

Family: Rutaceae

Order: Sapindales

Class:

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|24461866|gb|AAN62353.1|AF506028_20 NBS-LRR type disease resistance protein [Citrus trifoliata] Back     alignment and taxonomy information
>gi|24461865|gb|AAN62352.1|AF506028_19 NBS-LRR type disease resistance protein [Citrus trifoliata] Back     alignment and taxonomy information
>gi|24461861|gb|AAN62348.1|AF506028_15 NBS-LRR type disease resistance protein [Citrus trifoliata] Back     alignment and taxonomy information
>gi|24461864|gb|AAN62351.1|AF506028_18 NBS-LRR type disease resistance protein [Citrus trifoliata] Back     alignment and taxonomy information
>gi|15080718|gb|AAK83559.1|AF278857_1 putative disease resistance gene protein [Citrus trifoliata] Back     alignment and taxonomy information
>gi|225442867|ref|XP_002281592.1| PREDICTED: probable disease resistance protein At5g63020-like [Vitis vinifera] Back     alignment and taxonomy information
>gi|359482672|ref|XP_003632805.1| PREDICTED: probable disease resistance protein At1g12280-like [Vitis vinifera] Back     alignment and taxonomy information
>gi|225443158|ref|XP_002263674.1| PREDICTED: probable disease resistance protein At5g63020-like [Vitis vinifera] Back     alignment and taxonomy information
>gi|147852651|emb|CAN80649.1| hypothetical protein VITISV_017542 [Vitis vinifera] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query680
TAIR|locus:2166320888 AT5G63020 [Arabidopsis thalian 0.389 0.298 0.454 1.3e-98
TAIR|locus:2034770894 SUMM2 "AT1G12280" [Arabidopsis 0.416 0.316 0.447 2.3e-87
TAIR|locus:2201996889 RPS5 "AT1G12220" [Arabidopsis 0.386 0.295 0.454 6.7e-87
TAIR|locus:2201986885 RFL1 "AT1G12210" [Arabidopsis 0.383 0.294 0.450 2.3e-85
TAIR|locus:2171589 948 AT5G47260 [Arabidopsis thalian 0.379 0.272 0.417 1.4e-83
TAIR|locus:2008440899 AT1G61180 [Arabidopsis thalian 0.383 0.290 0.420 5.7e-81
TAIR|locus:2036214851 AT1G15890 [Arabidopsis thalian 0.383 0.306 0.419 1.9e-80
TAIR|locus:2008510 967 AT1G61190 "AT1G61190" [Arabido 0.417 0.293 0.407 2e-79
TAIR|locus:2034765884 AT1G12290 [Arabidopsis thalian 0.605 0.466 0.341 2.6e-79
TAIR|locus:2031366898 AT1G63350 "AT1G63350" [Arabido 0.385 0.291 0.419 5e-77
TAIR|locus:2166320 AT5G63020 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
 Score = 613 (220.8 bits), Expect = 1.3e-98, Sum P(3) = 1.3e-98
 Identities = 124/273 (45%), Positives = 183/273 (67%)

Query:   186 EKVGEETLDSHHDILELAQTVTKECGGSPLALITIGRAMAYKKKPEEWRYAIEVLRKSSS 245
             +KVGE TL SH +I  +A+TV K+C G PLAL  IG  MAYK+  +EWR AI+VL  SS+
Sbjct:   322 KKVGEITLGSHPEIPTVARTVAKKCRGLPLALNVIGETMAYKRTVQEWRSAIDVLT-SSA 380

Query:   246 SEFAGLVKEVYPLLKFSYDSLQNDVIRSCFLYCCLYPEDFAILKRDLIDCWIGEGFLDER 305
             +EF+G+  E+ P+LK+SYD+L+++ ++ CF YC L+PED  I K DL+D WIGEGF+D R
Sbjct:   381 AEFSGMEDEILPILKYSYDNLKSEQLKLCFQYCALFPEDHNIEKNDLVDYWIGEGFID-R 439

Query:   306 DSFSAQNQGYYIVGTLVHAWLLEEVGDDKVKLHGVLHDMALWISCEIEEEKENFLVCAGR 365
             +   A+NQGY I+G LV + LL E   + VK+H V+ +MALWI+ +  ++KENF+V AG 
Sbjct:   440 NKGKAENQGYEIIGILVRSCLLMEENQETVKMHDVVREMALWIASDFGKQKENFIVQAGL 499

Query:   366 GLKEAPEVKEWETVRRLSLMQNQIKILSEAPTCPHL-----HYEFK-MITDGFFQFMPLL 419
               +  PE+++W+  RR+SLM N I+ + +AP  P L        F   I+  FF+ MP+L
Sbjct:   500 QSRNIPEIEKWKVARRVSLMFNNIESIRDAPESPQLITLLLRKNFLGHISSSFFRLMPML 559

Query:   420 KVLNMSRETNIKELLGELKALVNLKCVNLEWAR 452
              VL++S   +++ L  E+   V+L+ ++L   R
Sbjct:   560 VVLDLSMNRDLRHLPNEISECVSLQYLSLSRTR 592


GO:0005634 "nucleus" evidence=ISM
GO:0006952 "defense response" evidence=IEA;ISS
GO:0043531 "ADP binding" evidence=IEA
TAIR|locus:2034770 SUMM2 "AT1G12280" [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
TAIR|locus:2201996 RPS5 "AT1G12220" [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
TAIR|locus:2201986 RFL1 "AT1G12210" [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
TAIR|locus:2171589 AT5G47260 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
TAIR|locus:2008440 AT1G61180 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
TAIR|locus:2036214 AT1G15890 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
TAIR|locus:2008510 AT1G61190 "AT1G61190" [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
TAIR|locus:2034765 AT1G12290 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
TAIR|locus:2031366 AT1G63350 "AT1G63350" [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server ?

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software ?

No EC number assignment, probably not an enzyme!


Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING ?

Fail to connect to STRING server


Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query680
pfam00931285 pfam00931, NB-ARC, NB-ARC domain 6e-27
>gnl|CDD|216202 pfam00931, NB-ARC, NB-ARC domain Back     alignment and domain information
 Score =  110 bits (278), Expect = 6e-27
 Identities = 46/120 (38%), Positives = 68/120 (56%), Gaps = 3/120 (2%)

Query: 187 KVGEETLDSHHDILELAQTVTKECGGSPLALITIGRAMAYKKKPEEWRYAIEVLRKSSSS 246
           KV E+ L    ++ E+A+ + ++C G PLAL  +G  +A+K   +EW + +E L     +
Sbjct: 168 KVFEKELPPCPELEEVAKEIVEKCKGLPLALKVLGGLLAFKSTVQEWEHVLEQLNN-ELA 226

Query: 247 EFAGLVKEVYPLLKFSYDSLQNDVIRSCFLYCCLYPEDFAILKRDLIDCWIGEGFLDERD 306
              GL  EV  +L  SYD+L    ++ CFLY  L+PED+ I K  LI  WI EGF+   D
Sbjct: 227 GRDGL-NEVLSILSLSYDNL-PMHLKRCFLYLALFPEDYNIRKEQLIKLWIAEGFVIPSD 284


Length = 285

Conserved Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 680
KOG4658889 consensus Apoptotic ATPase [Signal transduction me 100.0
PLN03210 1153 Resistant to P. syringae 6; Provisional 100.0
PF00931287 NB-ARC: NB-ARC domain; InterPro: IPR002182 This is 99.8
PLN03210 1153 Resistant to P. syringae 6; Provisional 99.69
KOG0444 1255 consensus Cytoskeletal regulator Flightless-I (con 99.67
PLN00113 968 leucine-rich repeat receptor-like protein kinase; 99.62
PLN00113 968 leucine-rich repeat receptor-like protein kinase; 99.58
KOG0444 1255 consensus Cytoskeletal regulator Flightless-I (con 99.52
KOG4194 873 consensus Membrane glycoprotein LIG-1 [Signal tran 99.5
KOG4194 873 consensus Membrane glycoprotein LIG-1 [Signal tran 99.42
KOG0472565 consensus Leucine-rich repeat protein [Function un 99.41
PRK15387 788 E3 ubiquitin-protein ligase SspH2; Provisional 99.24
KOG0617264 consensus Ras suppressor protein (contains leucine 99.19
KOG0472 565 consensus Leucine-rich repeat protein [Function un 99.17
KOG0618 1081 consensus Serine/threonine phosphatase 2C containi 99.13
PRK15370 754 E3 ubiquitin-protein ligase SlrP; Provisional 99.1
KOG4237 498 consensus Extracellular matrix protein slit, conta 99.04
PRK15370 754 E3 ubiquitin-protein ligase SlrP; Provisional 99.02
KOG0617264 consensus Ras suppressor protein (contains leucine 99.01
KOG4658889 consensus Apoptotic ATPase [Signal transduction me 98.97
PRK15387 788 E3 ubiquitin-protein ligase SspH2; Provisional 98.96
KOG0618 1081 consensus Serine/threonine phosphatase 2C containi 98.77
KOG4237498 consensus Extracellular matrix protein slit, conta 98.6
cd00116319 LRR_RI Leucine-rich repeats (LRRs), ribonuclease i 98.59
cd00116319 LRR_RI Leucine-rich repeats (LRRs), ribonuclease i 98.55
KOG3207505 consensus Beta-tubulin folding cofactor E [Posttra 98.44
PF14580175 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ 98.44
KOG1259490 consensus Nischarin, modulator of integrin alpha5 98.43
KOG2120419 consensus SCF ubiquitin ligase, Skp2 component [Po 98.4
KOG0532 722 consensus Leucine-rich repeat (LRR) protein, conta 98.4
KOG0532 722 consensus Leucine-rich repeat (LRR) protein, conta 98.38
PF1385561 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF 98.34
KOG3207 505 consensus Beta-tubulin folding cofactor E [Posttra 98.33
KOG1259490 consensus Nischarin, modulator of integrin alpha5 98.22
PF14580175 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ 98.11
COG4886394 Leucine-rich repeat (LRR) protein [Function unknow 98.11
PRK15386 426 type III secretion protein GogB; Provisional 98.06
PF1279944 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ 98.04
KOG4341483 consensus F-box protein containing LRR [General fu 98.01
PF1385561 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF 97.97
COG4886394 Leucine-rich repeat (LRR) protein [Function unknow 97.96
KOG2120419 consensus SCF ubiquitin ligase, Skp2 component [Po 97.92
KOG4341483 consensus F-box protein containing LRR [General fu 97.72
KOG1859 1096 consensus Leucine-rich repeat proteins [General fu 97.68
KOG3665 699 consensus ZYG-1-like serine/threonine protein kina 97.58
PLN03150623 hypothetical protein; Provisional 97.57
PRK15386 426 type III secretion protein GogB; Provisional 97.53
PF1279944 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ 97.47
KOG2982418 consensus Uncharacterized conserved protein [Funct 97.34
PLN03150623 hypothetical protein; Provisional 97.31
KOG1909382 consensus Ran GTPase-activating protein [RNA proce 97.29
KOG0531414 consensus Protein phosphatase 1, regulatory subuni 97.27
KOG1909382 consensus Ran GTPase-activating protein [RNA proce 97.25
KOG1859 1096 consensus Leucine-rich repeat proteins [General fu 97.24
KOG0531414 consensus Protein phosphatase 1, regulatory subuni 97.19
KOG2982418 consensus Uncharacterized conserved protein [Funct 97.06
KOG4579177 consensus Leucine-rich repeat (LRR) protein associ 96.95
KOG3665 699 consensus ZYG-1-like serine/threonine protein kina 96.79
KOG1947482 consensus Leucine rich repeat proteins, some prote 95.88
KOG1947482 consensus Leucine rich repeat proteins, some prote 95.66
KOG3864221 consensus Uncharacterized conserved protein [Funct 95.61
KOG1644233 consensus U2-associated snRNP A' protein [RNA proc 95.24
PF0056022 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le 95.23
KOG1644233 consensus U2-associated snRNP A' protein [RNA proc 94.81
PF05659147 RPW8: Arabidopsis broad-spectrum mildew resistance 94.6
KOG2739260 consensus Leucine-rich acidic nuclear protein [Cel 94.56
PF0056022 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le 94.11
KOG3864221 consensus Uncharacterized conserved protein [Funct 93.8
KOG2739260 consensus Leucine-rich acidic nuclear protein [Cel 93.79
PF13306129 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_ 93.29
PF1350417 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OO 92.86
KOG4579177 consensus Leucine-rich repeat (LRR) protein associ 92.77
PF1350417 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OO 91.65
KOG2123 388 consensus Uncharacterized conserved protein [Funct 90.26
smart0037026 LRR Leucine-rich repeats, outliers. 90.15
smart0036926 LRR_TYP Leucine-rich repeats, typical (most popula 90.15
COG5238388 RNA1 Ran GTPase-activating protein (RanGAP) involv 89.68
KOG2123388 consensus Uncharacterized conserved protein [Funct 88.91
PF12061402 DUF3542: Protein of unknown function (DUF3542); In 86.02
KOG0473326 consensus Leucine-rich repeat protein [Function un 83.71
COG5238388 RNA1 Ran GTPase-activating protein (RanGAP) involv 83.6
PRK04841 903 transcriptional regulator MalT; Provisional 80.88
>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] Back     alignment and domain information
Probab=100.00  E-value=4.6e-76  Score=667.89  Aligned_cols=640  Identities=35%  Similarity=0.597  Sum_probs=508.5

Q ss_pred             hhhhhhhhhccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcccchHHHHHHHHHHHHHHHHHHHHHHHhHH
Q 041114           14 FNRCLDCFLGKAACTRNLQDNVAALAIELAKLIAAKNNLITRVLDAERQQLRRLDQVQVWLSRVEAVKTETDELIRRSSK   93 (680)
Q Consensus        14 ~~~l~~~~~~~~~~~~~~~~~~~~L~~~l~~l~a~~~~~~~~l~~ae~~~~~~~~~v~~Wl~~v~~~~~d~ed~ld~~~~   93 (680)
                      ++++++.+.+++..+.+.++++..|++.+..|+.+       ++||++++.. ...+..|.+.+++++|+++|+++.|..
T Consensus         9 ~~~~~~~l~~~~~~~~~~~~~i~~Lk~~L~~l~~~-------l~d~~a~~~~-~~~~~~~~e~~~~~~~~~e~~~~~~~v   80 (889)
T KOG4658|consen    9 VEKLDQLLNRESECLDGKDNYILELKENLKALQSA-------LEDLDAKRDD-LERRVNWEEDVGDLVYLAEDIIWLFLV   80 (889)
T ss_pred             hhhHHHHHHHHHHHHhchHHHHHHHHHHHHHHHHH-------HHHHHhhcch-HHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            67788899999999999999999999999999999       9999999988 888999999999999999999998865


Q ss_pred             Hhc----------------ccCCCCccCCCchhhhhHHHHHHHHHHHHHHHHhcCCceeecc-CCCCCCcccccccccc-
Q 041114           94 EID----------------KLCPRAYCSKSCKSSYKFRKQVAKKLRDVRTLIGEGVFEVVAE-RPPQPVADEIPTEQIV-  155 (680)
Q Consensus        94 ~~~----------------~~~~~~~~~~~~~~~~~~~~~i~~~~~~v~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~v-  155 (680)
                      +..                +.|+.++|+..+...|.+++++-+++++++.+..++.|..++. ..|......+|..++. 
T Consensus        81 ~~~~~~~~~~l~~~~~~~~~~c~~~~~~~~~~~~~~~~~rv~~~l~~ve~l~~~~~~~~~~~~~~~~~~~e~~~~~~~~~  160 (889)
T KOG4658|consen   81 EEIERKANDLLSTRSVERQRLCLCGFCSKNVSDSYKYGKRVSKVLREVESLGSKGVFEVVGESLDPREKVETRPIQSESD  160 (889)
T ss_pred             HHHHHHHhHHhhhhHHHHHHHhhhhhHhHhhhhhHhHHHHHHHHHHHHHHhccccceecccccccchhhcccCCCCcccc
Confidence            543                2377788888888899999999999999999999988887765 3444455666665554 


Q ss_pred             ccHHHHHHHHHHHhhhccccceeeeccccc--------------------------------------------------
Q 041114          156 EGLQSQLKQVWRCLVEESIGIIGLYGMGSV--------------------------------------------------  185 (680)
Q Consensus       156 ~gr~~~~~~i~~~L~~~~~~vi~i~GmgGi--------------------------------------------------  185 (680)
                      ||.+.+++++|+.|.+++.+|+|||||||+                                                  
T Consensus       161 VG~e~~~~kl~~~L~~d~~~iv~i~GMGGvGKTTL~~qi~N~~~~v~~~Fd~~iWV~VSk~f~~~~iq~~Il~~l~~~~~  240 (889)
T KOG4658|consen  161 VGLETMLEKLWNRLMEDDVGIVGIYGMGGVGKTTLARQIFNKFDEVGNHFDGVIWVVVSKEFTTRKIQQTILERLGLLDE  240 (889)
T ss_pred             ccHHHHHHHHHHHhccCCCCEEEEECCCcccHHHHHHHHhcccchhcccCceEEEEEEcccccHHhHHHHHHHHhccCCc
Confidence            799999999999999988899999999999                                                  


Q ss_pred             --------------------------------------------------------------------------------
Q 041114          186 --------------------------------------------------------------------------------  185 (680)
Q Consensus       186 --------------------------------------------------------------------------------  185 (680)
                                                                                                      
T Consensus       241 ~~~~~~~~~~~~~i~~~L~~krfllvLDDIW~~~dw~~I~~~~p~~~~g~KvvlTTRs~~V~~~~m~~~~~~~v~~L~~~  320 (889)
T KOG4658|consen  241 EWEDKEEDELASKLLNLLEGKRFLLVLDDIWEEVDWDKIGVPFPSRENGSKVVLTTRSEEVCGRAMGVDYPIEVECLTPE  320 (889)
T ss_pred             ccchhhHHHHHHHHHHHhccCceEEEEecccccccHHhcCCCCCCccCCeEEEEEeccHhhhhccccCCccccccccCcc
Confidence                                                                                            


Q ss_pred             -------eecCccccCCCccHHHHHHHHHHHhCCChhHHHHHHHHhccCCCHHHHHHHHHHHhcCCCccccCChhhHHHH
Q 041114          186 -------EKVGEETLDSHHDILELAQTVTKECGGSPLALITIGRAMAYKKKPEEWRYAIEVLRKSSSSEFAGLVKEVYPL  258 (680)
Q Consensus       186 -------~~~~~~~~~~~~~l~~~~~~I~~kc~GlPLai~~lg~~L~~k~~~~~W~~~l~~l~~~~~~~~~~~~~~i~~~  258 (680)
                             ++++......+++++++|++||++|+|||||++++|++|+.|++.++|+++.+.+.++...+.+++.+.++++
T Consensus       321 eaW~LF~~~v~~~~~~~~~~i~~lak~v~~kC~GLPLAl~viG~~ma~K~t~~eW~~~~~~l~s~~~~~~~~~~~~i~~i  400 (889)
T KOG4658|consen  321 EAWDLFQKKVGPNTLGSHPDIEELAKEVAEKCGGLPLALNVLGGLLACKKTVQEWRRALNVLKSSLAADFSGMEESILPI  400 (889)
T ss_pred             ccHHHHHHhhccccccccccHHHHHHHHHHHhCChHHHHHHHHHHhcCCCcHHHHHHHHccccccccCCCCchhhhhHHh
Confidence                   4455554456677999999999999999999999999999999999999999999882256667778899999


Q ss_pred             HHHhHhcCCchhHHHHHHHhcccCCCcccChHHHHHHHHHcCCcCC-CChhhHHHHHHHHHHHHHHccccccc----Ccc
Q 041114          259 LKFSYDSLQNDVIRSCFLYCCLYPEDFAILKRDLIDCWIGEGFLDE-RDSFSAQNQGYYIVGTLVHAWLLEEV----GDD  333 (680)
Q Consensus       259 L~~Sy~~L~~~~lk~cfl~~s~Fp~~~~i~~~~Li~~Wiaeg~i~~-~~~~~~~~~g~~~~~~L~~~~ll~~~----~~~  333 (680)
                      |++|||+||+ ++|+||+|||+||+||.|++++||.+||||||+.. ..++.+++.|+.|+.+|++++|++..    ...
T Consensus       401 LklSyd~L~~-~lK~CFLycalFPED~~I~~e~Li~yWiaEGfi~~~~~~~~~~d~G~~~i~~LV~~~Ll~~~~~~~~~~  479 (889)
T KOG4658|consen  401 LKLSYDNLPE-ELKSCFLYCALFPEDYEIKKEKLIEYWIAEGFIDPLDGGETAEDVGYDYIEELVRASLLIEERDEGRKE  479 (889)
T ss_pred             hhccHhhhhH-HHHHHHHhhccCCcccccchHHHHHHHHhccCcCccccccchhcchHHHHHHHHHHHHHhhccccccee
Confidence            9999999996 99999999999999999999999999999999999 77899999999999999999999986    348


Q ss_pred             cEEechhHHHHHHHHHhhhhcccccEEEecCCCcccccccccccceEEEEeecccccccccCCCCccc------cc--cc
Q 041114          334 KVKLHGVLHDMALWISCEIEEEKENFLVCAGRGLKEAPEVKEWETVRRLSLMQNQIKILSEAPTCPHL------HY--EF  405 (680)
Q Consensus       334 ~~~mhdl~~d~a~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~lsl~~~~~~~l~~~~~~~~L------~~--~l  405 (680)
                      +|+|||+|||||.++|++.+..++++++..+.+..+.|....|..+|++++.++.+..++....++++      .+  .+
T Consensus       480 ~~kmHDvvRe~al~ias~~~~~~e~~iv~~~~~~~~~~~~~~~~~~rr~s~~~~~~~~~~~~~~~~~L~tLll~~n~~~l  559 (889)
T KOG4658|consen  480 TVKMHDVVREMALWIASDFGKQEENQIVSDGVGLSEIPQVKSWNSVRRMSLMNNKIEHIAGSSENPKLRTLLLQRNSDWL  559 (889)
T ss_pred             EEEeeHHHHHHHHHHhccccccccceEEECCcCccccccccchhheeEEEEeccchhhccCCCCCCccceEEEeecchhh
Confidence            99999999999999999888877888888877888899999999999999999999999888888876      33  37


Q ss_pred             cccchhhhccCCcceEEEccCCCCccccchhhhccCCCCEEeccCCCCccccchhhhcCCCCCcEeeccCCcc----hhh
Q 041114          406 KMITDGFFQFMPLLKVLNMSRETNIKELLGELKALVNLKCVNLEWARDLVTIPLEVISNFSKLRVLRLFGTVL----AKE  481 (680)
Q Consensus       406 ~~lp~~~~~~l~~Lr~LdL~~~~~i~~lP~~i~~L~~Lr~L~L~~~~~l~~lP~~~i~~L~~L~~L~l~~~~~----~~~  481 (680)
                      ..++..||..|+.||||||++|..+.+||++|++|.|||||+++++ .++.+|.+ +++|..|++|++..+..    +.-
T Consensus       560 ~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t-~I~~LP~~-l~~Lk~L~~Lnl~~~~~l~~~~~i  637 (889)
T KOG4658|consen  560 LEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDT-GISHLPSG-LGNLKKLIYLNLEVTGRLESIPGI  637 (889)
T ss_pred             hhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCC-CccccchH-HHHHHhhheeccccccccccccch
Confidence            8899999999999999999999999999999999999999999999 89999998 99999999999986542    122


Q ss_pred             hcCCCCCceeEEEecc--------------------------chhhhhhhhchhhhccccEEEEeccCCCCccccccccc
Q 041114          482 LLGLKHLEELDFTLRC--------------------------VHSLQILVSSNKLQSCTRALVLIRFKDSKSIDVIALAR  535 (680)
Q Consensus       482 l~~L~~L~~L~i~~~~--------------------------~~~l~~l~~~~~l~~~L~~L~l~~~~~~~~~~~~~l~~  535 (680)
                      +..|++|+.|.+....                          ...+..+.....+.+..+.+.+.++. ..... +++..
T Consensus       638 ~~~L~~Lr~L~l~~s~~~~~~~~l~el~~Le~L~~ls~~~~s~~~~e~l~~~~~L~~~~~~l~~~~~~-~~~~~-~~~~~  715 (889)
T KOG4658|consen  638 LLELQSLRVLRLPRSALSNDKLLLKELENLEHLENLSITISSVLLLEDLLGMTRLRSLLQSLSIEGCS-KRTLI-SSLGS  715 (889)
T ss_pred             hhhcccccEEEeeccccccchhhHHhhhcccchhhheeecchhHhHhhhhhhHHHHHHhHhhhhcccc-cceee-ccccc
Confidence            2335666666554322                          11111222222222233333333322 12222 47788


Q ss_pred             CCCCCEEEEeccCCcceeecccCCCCccCCCCCC-CCCCccEEeeeCCCCCCCCCCcCCCCCCCEEeEecCcchhHhhhc
Q 041114          536 LKHLSTLHFSKCEELEEWKTDYTSGTVLKSPQPF-VFCSLHKVTITFCPKLKGLTFLVFAPNLKCLSLFDCTAMEEIISA  614 (680)
Q Consensus       536 l~~L~~L~l~~~~~l~~l~~~~~~~~~l~~~~~~-~l~~L~~L~L~~c~~l~~l~~l~~l~~L~~L~l~~c~~l~~i~~~  614 (680)
                      +.+|+.|.+.+|...+.. ..+....     ... .|+++.++.+.+|...+.+.|....|+|+.|.+..|..++++++.
T Consensus       716 l~~L~~L~i~~~~~~e~~-~~~~~~~-----~~~~~f~~l~~~~~~~~~~~r~l~~~~f~~~L~~l~l~~~~~~e~~i~~  789 (889)
T KOG4658|consen  716 LGNLEELSILDCGISEIV-IEWEESL-----IVLLCFPNLSKVSILNCHMLRDLTWLLFAPHLTSLSLVSCRLLEDIIPK  789 (889)
T ss_pred             ccCcceEEEEcCCCchhh-ccccccc-----chhhhHHHHHHHHhhccccccccchhhccCcccEEEEecccccccCCCH
Confidence            999999999999876532 2222110     001 255666666667766666666666777777777777666655332


Q ss_pred             CC-----------CC----------------------CCCcccccCccccccCCCCCCCCccccCc--ceEEecc-cccc
Q 041114          615 GK-----------FV----------------------HTPEMMGNTMDPCAKLRKLPLDSNSALEH--KIAIRGE-AGWW  658 (680)
Q Consensus       615 ~~-----------~~----------------------~lp~L~~L~i~~C~~L~~lP~~~~~~l~~--L~i~~~~-~~~~  658 (680)
                      ..           +.                      .+++|+.+.+..||+++.+|.........  -.+...+ .+|.
T Consensus       790 ~k~~~~l~~~i~~f~~~~~l~~~~~l~~l~~i~~~~l~~~~l~~~~ve~~p~l~~~P~~~~~~i~~~~~~~~~~~~~~~~  869 (889)
T KOG4658|consen  790 LKALLELKELILPFNKLEGLRMLCSLGGLPQLYWLPLSFLKLEELIVEECPKLGKLPLLSTLTIVGCEEKLKEYPDGEWL  869 (889)
T ss_pred             HHHhhhcccEEecccccccceeeecCCCCceeEecccCccchhheehhcCcccccCccccccceeccccceeecCCccce
Confidence            10           00                      13344555699999999999875542221  1233333 5678


Q ss_pred             ccCccCchhhhccc
Q 041114          659 GCLQWENEATQIAF  672 (680)
Q Consensus       659 ~~l~w~~~~~~~~~  672 (680)
                      +.++|++..++..|
T Consensus       870 ~~v~~~~~~~~~~~  883 (889)
T KOG4658|consen  870 EGVYWEDELTKLRF  883 (889)
T ss_pred             eeEEehhhhhhhhc
Confidence            88899998888777



>PLN03210 Resistant to P Back     alignment and domain information
>PF00931 NB-ARC: NB-ARC domain; InterPro: IPR002182 This is the NB-ARC domain, a novel signalling motif found in bacteria and eukaryotes, shared by plant resistance gene products and regulators of cell death in animals [] Back     alignment and domain information
>PLN03210 Resistant to P Back     alignment and domain information
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] Back     alignment and domain information
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] Back     alignment and domain information
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] Back     alignment and domain information
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] Back     alignment and domain information
>KOG0472 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional Back     alignment and domain information
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] Back     alignment and domain information
>KOG0472 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] Back     alignment and domain information
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional Back     alignment and domain information
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] Back     alignment and domain information
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional Back     alignment and domain information
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] Back     alignment and domain information
>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] Back     alignment and domain information
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional Back     alignment and domain information
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] Back     alignment and domain information
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] Back     alignment and domain information
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A Back     alignment and domain information
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] Back     alignment and domain information
>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] Back     alignment and domain information
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] Back     alignment and domain information
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A Back     alignment and domain information
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] Back     alignment and domain information
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A Back     alignment and domain information
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
>PRK15386 type III secretion protein GogB; Provisional Back     alignment and domain information
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B Back     alignment and domain information
>KOG4341 consensus F-box protein containing LRR [General function prediction only] Back     alignment and domain information
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A Back     alignment and domain information
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>KOG4341 consensus F-box protein containing LRR [General function prediction only] Back     alignment and domain information
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] Back     alignment and domain information
>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] Back     alignment and domain information
>PLN03150 hypothetical protein; Provisional Back     alignment and domain information
>PRK15386 type III secretion protein GogB; Provisional Back     alignment and domain information
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B Back     alignment and domain information
>KOG2982 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>PLN03150 hypothetical protein; Provisional Back     alignment and domain information
>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] Back     alignment and domain information
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] Back     alignment and domain information
>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] Back     alignment and domain information
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] Back     alignment and domain information
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] Back     alignment and domain information
>KOG2982 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] Back     alignment and domain information
>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] Back     alignment and domain information
>KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only] Back     alignment and domain information
>KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only] Back     alignment and domain information
>KOG3864 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] Back     alignment and domain information
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] Back     alignment and domain information
>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] Back     alignment and domain information
>PF05659 RPW8: Arabidopsis broad-spectrum mildew resistance protein RPW8; InterPro: IPR008808 This entry represents the RPW8 domain found in several broad-spectrum mildew resistance proteins from Arabidopsis thaliana and other dicots Back     alignment and domain information
>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] Back     alignment and domain information
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] Back     alignment and domain information
>KOG3864 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] Back     alignment and domain information
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A Back     alignment and domain information
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D Back     alignment and domain information
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] Back     alignment and domain information
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D Back     alignment and domain information
>KOG2123 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>smart00370 LRR Leucine-rich repeats, outliers Back     alignment and domain information
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily Back     alignment and domain information
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>KOG2123 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>PF12061 DUF3542: Protein of unknown function (DUF3542); InterPro: IPR021929 R1 is a gene for resistance to late blight, the most destructive disease in potato cultivation worldwide Back     alignment and domain information
>KOG0473 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>PRK04841 transcriptional regulator MalT; Provisional Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

No homologous structure with e-value below 0.005

Structure Templates Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query680
2a5y_B549 CED-4; apoptosis; HET: ATP; 2.60A {Caenorhabditis 7e-24
1z6t_A591 APAF-1, apoptotic protease activating factor 1; ca 2e-21
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 3e-16
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 1e-14
2id5_A 477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 1e-09
2id5_A 477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 4e-07
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 2e-08
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 1e-07
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 1e-04
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 3e-08
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 3e-08
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 3e-06
3fxi_A 605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 5e-05
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 1e-07
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 6e-07
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 7e-05
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 3e-07
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 5e-06
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 2e-05
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 3e-07
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 8e-07
3vq2_A 606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 4e-07
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 8e-07
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 3e-05
3vq2_A 606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 4e-04
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 5e-07
2z7x_B 520 TOLL-like receptor 1, variable lymphocyte recepto; 5e-07
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 5e-07
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 2e-04
2z81_A 549 CD282 antigen, TOLL-like receptor 2, variable lymp 8e-07
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 1e-06
2z81_A 549 CD282 antigen, TOLL-like receptor 2, variable lymp 5e-06
3bz5_A 457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 1e-06
3v47_A 455 TOLL-like receptor 5B and variable lymphocyte REC 4e-06
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 5e-06
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 2e-04
3a79_B 562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 5e-06
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 6e-06
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 4e-05
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 6e-06
1o6v_A 466 Internalin A; bacterial infection, extracellular r 6e-06
1o6v_A466 Internalin A; bacterial infection, extracellular r 2e-05
1o6v_A 466 Internalin A; bacterial infection, extracellular r 3e-04
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 6e-06
3zyj_A 440 Leucine-rich repeat-containing protein 4C; cell ad 1e-05
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 2e-05
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 9e-05
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 2e-05
4fmz_A347 Internalin; leucine rich repeat, structural genomi 2e-05
4fmz_A347 Internalin; leucine rich repeat, structural genomi 2e-05
2z63_A 570 TOLL-like receptor 4, variable lymphocyte recepto; 2e-05
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 4e-05
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 7e-05
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 2e-05
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 1e-04
3zyi_A 452 Leucine-rich repeat-containing protein 4; cell adh 3e-05
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 4e-05
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 5e-05
4ecn_A 876 Leucine-rich repeat protein; leucine-rich repeats, 7e-04
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 6e-05
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 6e-05
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 1e-04
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 2e-04
4ezg_A197 Putative uncharacterized protein; internalin-A, le 2e-04
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 6e-04
>2a5y_B CED-4; apoptosis; HET: ATP; 2.60A {Caenorhabditis elegans} SCOP: a.4.5.80 a.77.1.3 c.37.1.20 PDB: 3lqq_A* 3lqr_A* Length = 549 Back     alignment and structure
 Score =  105 bits (262), Expect = 7e-24
 Identities = 30/232 (12%), Positives = 66/232 (28%), Gaps = 19/232 (8%)

Query: 201 ELAQTVTKECGGSPLALITIGRAMAYKKKPEEWRYAIEVLRKSSSS----EFAGLVKEVY 256
           ++     +   G+P  L+   ++    K  E+       L                K + 
Sbjct: 317 DVLNKTIELSSGNPATLMMFFKSCE-PKTFEKMAQLNNKLESRGLVGVECITPYSYKSLA 375

Query: 257 PLLKFSYDSLQNDVIRSCFLYCCLYPEDFAILKRDLIDCWIGEGFLDERDSFSAQNQGYY 316
             L+   + L ++  RS   +  + P    I  +        +   +E +     ++   
Sbjct: 376 MALQRCVEVLSDED-RSALAFAVVMPPGVDIPVKLWSCVIPVDICSNEEE--QLDDEVAD 432

Query: 317 IVGTLVHAWLLEEVGDDKV---KLHGVLHDMAL------WISCEIEEEKENFLVCAGRGL 367
            +  L     L       V   K+  ++H           I+  I   ++  L      +
Sbjct: 433 RLKRLSKRGALLSGKRMPVLTFKIDHIIHMFLKHVVDAQTIANGISILEQRLLEIGNNNV 492

Query: 368 KEAPE--VKEWETVRRLSLMQNQIKILSEAPTCPHLHYEFKMITDGFFQFMP 417
                     ++  RR S  +   K   E    P    +F  +   F+  + 
Sbjct: 493 SVPERHIPSHFQKFRRSSASEMYPKTTEETVIRPEDFPKFMQLHQKFYDSLK 544


>1z6t_A APAF-1, apoptotic protease activating factor 1; caspase activation, ADP, nucleotide binding, CARD, apoptosis; HET: ADP; 2.21A {Homo sapiens} Length = 591 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure

Structure Templates Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query680
2a5y_B549 CED-4; apoptosis; HET: ATP; 2.60A {Caenorhabditis 99.9
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 99.81
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 99.8
3sfz_A 1249 APAF-1, apoptotic peptidase activating factor 1; a 99.79
2id5_A 477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 99.76
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 99.76
4fmz_A347 Internalin; leucine rich repeat, structural genomi 99.75
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 99.75
4fmz_A347 Internalin; leucine rich repeat, structural genomi 99.73
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 99.72
1o6v_A466 Internalin A; bacterial infection, extracellular r 99.71
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 99.71
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 99.7
3vq2_A 606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 99.7
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 99.7
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 99.69
2id5_A 477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 99.69
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 99.69
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 99.69
3oja_B 597 Anopheles plasmodium-responsive leucine-rich REPE 99.68
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 99.68
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 99.68
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 99.68
1ziw_A 680 TOLL-like receptor 3; innate immunity, immune syst 99.67
1o6v_A466 Internalin A; bacterial infection, extracellular r 99.67
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 99.67
2z7x_B 520 TOLL-like receptor 1, variable lymphocyte recepto; 99.67
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 99.67
3zyi_A 452 Leucine-rich repeat-containing protein 4; cell adh 99.67
3t6q_A 606 CD180 antigen; protein-protein complex, leucine ri 99.66
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 99.66
2z81_A 549 CD282 antigen, TOLL-like receptor 2, variable lymp 99.65
3zyj_A 440 Leucine-rich repeat-containing protein 4C; cell ad 99.65
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 99.65
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 99.64
3bz5_A 457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 99.64
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 99.64
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 99.64
2z7x_B 520 TOLL-like receptor 1, variable lymphocyte recepto; 99.64
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 99.63
1z6t_A591 APAF-1, apoptotic protease activating factor 1; ca 99.63
2z63_A 570 TOLL-like receptor 4, variable lymphocyte recepto; 99.63
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 99.63
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 99.62
3a79_B 562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 99.62
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 99.62
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 99.61
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 99.61
3bz5_A 457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 99.61
2z63_A 570 TOLL-like receptor 4, variable lymphocyte recepto; 99.61
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 99.61
3rgz_A 768 Protein brassinosteroid insensitive 1; phytohormon 99.6
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 99.59
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 99.59
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 99.58
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 99.58
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 99.58
3a79_B 562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 99.58
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 99.58
3g06_A 622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 99.57
4g8a_A 635 TOLL-like receptor 4; leucine rich repeat MD-2 rel 99.56
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 99.56
2z81_A 549 CD282 antigen, TOLL-like receptor 2, variable lymp 99.55
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 99.55
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 99.55
3oja_A 487 Leucine-rich immune molecule 1; coiled-coil, helix 99.55
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 99.53
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 99.53
3qfl_A115 MLA10; coiled-coil, (CC) domain, NLRS, nucleotide- 99.52
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 99.52
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 99.52
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 99.51
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 99.51
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 99.51
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 99.51
3oja_A 487 Leucine-rich immune molecule 1; coiled-coil, helix 99.51
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 99.5
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 99.5
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 99.5
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 99.49
3g06_A 622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 99.49
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 99.47
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 99.47
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 99.46
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 99.45
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 99.44
1jl5_A 454 Outer protein YOPM; leucine-rich repeat, molecular 99.44
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 99.4
4glp_A310 Monocyte differentiation antigen CD14; alpha beta 99.4
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 99.37
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 99.36
3m19_A251 Variable lymphocyte receptor A diversity region; a 99.33
1m9s_A 605 Internalin B; cell invasion, GW domains, SH3 domai 99.32
4ezg_A197 Putative uncharacterized protein; internalin-A, le 99.32
3m19_A251 Variable lymphocyte receptor A diversity region; a 99.29
4glp_A310 Monocyte differentiation antigen CD14; alpha beta 99.28
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 99.26
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 99.26
2o6s_A208 Variable lymphocyte receptor B; leucine-rich repea 99.24
4g8a_A635 TOLL-like receptor 4; leucine rich repeat MD-2 rel 99.21
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 99.2
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 99.19
4ezg_A197 Putative uncharacterized protein; internalin-A, le 99.18
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 99.18
3cvr_A 571 Invasion plasmid antigen; leucine rich repeat and 99.14
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 99.14
3ogk_B 592 Coronatine-insensitive protein 1; leucine rich rep 99.14
3cvr_A 571 Invasion plasmid antigen; leucine rich repeat and 99.13
2o6s_A208 Variable lymphocyte receptor B; leucine-rich repea 99.11
3e6j_A229 Variable lymphocyte receptor diversity region; var 99.11
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 99.1
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 99.07
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 99.07
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 99.06
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 99.06
3e6j_A229 Variable lymphocyte receptor diversity region; var 99.05
4b8c_D 727 Glucose-repressible alcohol dehydrogenase transcr 99.05
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 99.03
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 99.02
2p1m_B 594 Transport inhibitor response 1 protein; F-BOX, leu 99.02
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 99.01
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 98.99
3sb4_A329 Hypothetical leucine rich repeat protein; LRR, rig 98.93
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 98.92
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 98.87
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 98.84
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 98.79
1w8a_A192 SLIT protein; signaling protein, secreted protein, 98.77
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 98.77
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 98.76
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 98.76
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 98.75
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 98.74
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 98.71
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 98.71
1w8a_A192 SLIT protein; signaling protein, secreted protein, 98.69
2r9u_A174 Variable lymphocyte receptor; adaptive immunity, V 98.69
2o6r_A177 Variable lymphocyte receptor B; leucine-rich repea 98.69
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 98.68
2o6r_A177 Variable lymphocyte receptor B; leucine-rich repea 98.67
3g39_A170 Variable lymphocyte receptor VLRB.2D; antibody, X- 98.63
3sb4_A329 Hypothetical leucine rich repeat protein; LRR, rig 98.59
4b8c_D 727 Glucose-repressible alcohol dehydrogenase transcr 98.54
2r9u_A174 Variable lymphocyte receptor; adaptive immunity, V 98.5
3g39_A170 Variable lymphocyte receptor VLRB.2D; antibody, X- 98.46
4fdw_A401 Leucine rich hypothetical protein; putative cell s 98.43
4fdw_A401 Leucine rich hypothetical protein; putative cell s 98.26
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 98.25
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 98.23
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 98.18
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 98.07
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 97.88
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 97.87
4fs7_A394 Uncharacterized protein; leucine-rich repeats, pro 97.57
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 97.56
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 97.4
3rw6_A267 Nuclear RNA export factor 1; retroviral constituti 97.36
4fs7_A394 Uncharacterized protein; leucine-rich repeats, pro 97.15
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 97.08
4gt6_A394 Cell surface protein; leucine rich repeats, putati 97.08
4gt6_A394 Cell surface protein; leucine rich repeats, putati 97.02
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 96.68
3rw6_A267 Nuclear RNA export factor 1; retroviral constituti 96.59
4h09_A379 Hypothetical leucine rich repeat protein; two LRR_ 96.17
3rfe_A130 Platelet glycoprotein IB beta chain; platelet surf 94.96
3rfe_A130 Platelet glycoprotein IB beta chain; platelet surf 90.53
4h09_A379 Hypothetical leucine rich repeat protein; two LRR_ 89.28
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 87.84
2qen_A350 Walker-type ATPase; unknown function; HET: ADP; 2. 81.07
>2a5y_B CED-4; apoptosis; HET: ATP; 2.60A {Caenorhabditis elegans} SCOP: a.4.5.80 a.77.1.3 c.37.1.20 PDB: 3lqq_A* 3lqr_A* Back     alignment and structure
Probab=99.90  E-value=6.2e-25  Score=244.68  Aligned_cols=143  Identities=13%  Similarity=0.134  Sum_probs=114.9

Q ss_pred             ccHHHHHHHHHHHhCCChhHHHHHHHHhccCCCHHHHHHHHHHHhcCCCccccCChhhHHHHHHHhHhcCCchhHHHHHH
Q 041114          197 HDILELAQTVTKECGGSPLALITIGRAMAYKKKPEEWRYAIEVLRKSSSSEFAGLVKEVYPLLKFSYDSLQNDVIRSCFL  276 (680)
Q Consensus       197 ~~l~~~~~~I~~kc~GlPLai~~lg~~L~~k~~~~~W~~~l~~l~~~~~~~~~~~~~~i~~~L~~Sy~~L~~~~lk~cfl  276 (680)
                      +++++++++|+++|+|+||||+++|+.|+.+ +   |+.+ +.+.. ..+...  .+++.+++.+||++||+ ++|.||+
T Consensus       313 ~~~~~~~~~I~~~c~GlPLAl~~~g~~l~~~-~---w~~~-~~l~~-~l~~~~--~~~i~~~l~~Sy~~L~~-~lk~~f~  383 (549)
T 2a5y_B          313 EKEEDVLNKTIELSSGNPATLMMFFKSCEPK-T---FEKM-AQLNN-KLESRG--LVGVECITPYSYKSLAM-ALQRCVE  383 (549)
T ss_dssp             CHHHHHHHHHHHHHTTCHHHHHHHHTTCCSS-S---HHHH-HHHHH-HHHHHC--SSTTCCCSSSSSSSHHH-HHHHHHH
T ss_pred             hhHHHHHHHHHHHhCCChHHHHHHHHHhccc-h---HHHH-HHhHH-Hhhccc--HHHHHHHHhcccccccH-HHHHHHh
Confidence            6678899999999999999999999999874 3   4443 44544 333221  23688999999999999 9999999


Q ss_pred             -----------HhcccCCCcccChHHHHHHHHHc--CCcCCCC-hhhHHHHHHHHHHHHHHccccccc---CcccEEech
Q 041114          277 -----------YCCLYPEDFAILKRDLIDCWIGE--GFLDERD-SFSAQNQGYYIVGTLVHAWLLEEV---GDDKVKLHG  339 (680)
Q Consensus       277 -----------~~s~Fp~~~~i~~~~Li~~Wiae--g~i~~~~-~~~~~~~g~~~~~~L~~~~ll~~~---~~~~~~mhd  339 (680)
                                 |||+||+++.|+    +++|+|+  ||+...+ ....++.++ ||++|+++||+++.   ....|+|||
T Consensus       384 ~Ls~~er~l~~~ls~fp~~~~i~----i~~w~a~~~G~i~~~~~~~~~~~~~~-~l~~L~~rsLl~~~~~~~~~~~~mHd  458 (549)
T 2a5y_B          384 VLSDEDRSALAFAVVMPPGVDIP----VKLWSCVIPVDICSNEEEQLDDEVAD-RLKRLSKRGALLSGKRMPVLTFKIDH  458 (549)
T ss_dssp             TSCHHHHHHTTGGGSSCTTCCEE----HHHHHHHSCC-------CCCTHHHHH-HHHHTTTBSSCSEEECSSSCEEECCH
T ss_pred             ccchhhhhHhhheeeeCCCCeee----eeeeeeeccceeccCCCCCCHHHHHH-HHHHHHHcCCeeEecCCCceEEEeCh
Confidence                       999999999999    8999999  9998844 666788888 99999999999986   345799999


Q ss_pred             hHHHHHHHHHhhhh
Q 041114          340 VLHDMALWISCEIE  353 (680)
Q Consensus       340 l~~d~a~~i~~~~~  353 (680)
                      ++|++|++++.+++
T Consensus       459 lv~~~a~~~~~~~~  472 (549)
T 2a5y_B          459 IIHMFLKHVVDAQT  472 (549)
T ss_dssp             HHHHHHHTTSCTHH
T ss_pred             HHHHHHHHHHHHHH
Confidence            99999999987743



>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Back     alignment and structure
>3sfz_A APAF-1, apoptotic peptidase activating factor 1; apoptosis, caspase activation, cytochrome C, procaspase-9, A nucleotide, cytosol; HET: ADP; 3.00A {Mus musculus} PDB: 3shf_A* 3iyt_A* 3iza_A* Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Back     alignment and structure
>1z6t_A APAF-1, apoptotic protease activating factor 1; caspase activation, ADP, nucleotide binding, CARD, apoptosis; HET: ADP; 2.21A {Homo sapiens} Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Back     alignment and structure
>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Back     alignment and structure
>3qfl_A MLA10; coiled-coil, (CC) domain, NLRS, nucleotide-binding domain, L rich repeat containing receptors, protein binding; 2.00A {Hordeum vulgare} Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Back     alignment and structure
>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Back     alignment and structure
>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Back     alignment and structure
>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Back     alignment and structure
>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Back     alignment and structure
>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Back     alignment and structure
>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Back     alignment and structure
>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Back     alignment and structure
>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Back     alignment and structure
>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Back     alignment and structure
>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Back     alignment and structure
>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Back     alignment and structure
>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Back     alignment and structure
>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Back     alignment and structure
>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} Back     alignment and structure
>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} Back     alignment and structure
>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Back     alignment and structure
>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Back     alignment and structure
>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A Back     alignment and structure
>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Back     alignment and structure
>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Back     alignment and structure
>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Back     alignment and structure
>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Back     alignment and structure
>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} Back     alignment and structure
>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Back     alignment and structure
>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Back     alignment and structure
>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} Back     alignment and structure
>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Back     alignment and structure
>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Back     alignment and structure
>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Back     alignment and structure
>2qen_A Walker-type ATPase; unknown function; HET: ADP; 2.25A {Pyrococcus abyssi} Back     alignment and structure

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query 680
d2a5yb3277 c.37.1.20 (B:109-385) CED-4, NB-ARC domain {Caenor 1e-05
d2omza2384 c.10.2.1 (A:33-416) Internalin A {Listeria monocyt 5e-05
>d2a5yb3 c.37.1.20 (B:109-385) CED-4, NB-ARC domain {Caenorhabditis elegans [TaxId: 6239]} Length = 277 Back     information, alignment and structure

class: Alpha and beta proteins (a/b)
fold: P-loop containing nucleoside triphosphate hydrolases
superfamily: P-loop containing nucleoside triphosphate hydrolases
family: Extended AAA-ATPase domain
domain: CED-4, NB-ARC domain
species: Caenorhabditis elegans [TaxId: 6239]
 Score = 45.6 bits (107), Expect = 1e-05
 Identities = 12/81 (14%), Positives = 25/81 (30%), Gaps = 9/81 (11%)

Query: 195 SHHDILELAQTVTKECGGSPLALITIGRAMAYKKKPEEWRYAIEVLRKSSSSEFAGLVKE 254
                 ++     +   G+P  L+   ++    K  E+       L           +  
Sbjct: 203 VGEKEEDVLNKTIELSSGNPATLMMFFKSCE-PKTFEKMAQLNNKLESRG-------LVG 254

Query: 255 VYPLLKFSYDSLQNDVIRSCF 275
           V  +  +SY SL    ++ C 
Sbjct: 255 VECITPYSYKSLAMA-LQRCV 274


>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 Back     information, alignment and structure

Homologous Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query680
d2a5yb3277 CED-4, NB-ARC domain {Caenorhabditis elegans [TaxI 99.65
d2omza2384 Internalin A {Listeria monocytogenes [TaxId: 1639] 99.58
d2omza2384 Internalin A {Listeria monocytogenes [TaxId: 1639] 99.58
d1xkua_305 Decorin {Cow (Bos taurus) [TaxId: 9913]} 99.55
d1ogqa_313 Polygalacturonase inhibiting protein PGIP {Kidney 99.55
d1h6ua2227 Internalin H {Listeria monocytogenes [TaxId: 1639] 99.52
d1h6ua2227 Internalin H {Listeria monocytogenes [TaxId: 1639] 99.52
d1xkua_305 Decorin {Cow (Bos taurus) [TaxId: 9913]} 99.48
d1p9ag_266 von Willebrand factor binding domain of glycoprote 99.47
d1p9ag_266 von Willebrand factor binding domain of glycoprote 99.46
d1h6ta2210 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.43
d2omxa2199 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.42
d1ozna_284 Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma 99.41
d1ogqa_313 Polygalacturonase inhibiting protein PGIP {Kidney 99.4
d1ozna_284 Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma 99.4
d1h6ta2210 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.36
d1xwdc1242 Follicle-stimulating hormone receptor {Human (Homo 99.34
d1jl5a_353 Leucine rich effector protein YopM {Yersinia pesti 99.34
d2omxa2199 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.34
d2astb2284 Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa 99.3
d2astb2284 Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa 99.3
d1xwdc1242 Follicle-stimulating hormone receptor {Human (Homo 99.27
d1dcea3124 Rab geranylgeranyltransferase alpha-subunit, C-ter 99.07
d1jl5a_353 Leucine rich effector protein YopM {Yersinia pesti 99.06
d1dcea3124 Rab geranylgeranyltransferase alpha-subunit, C-ter 98.99
d1a9na_162 Splicesomal U2A' protein {Human (Homo sapiens) [Ta 98.94
d1a9na_162 Splicesomal U2A' protein {Human (Homo sapiens) [Ta 98.9
d1m9la_198 Outer arm dynein light chain 1 {Green algae (Chlam 98.79
d1m9la_198 Outer arm dynein light chain 1 {Green algae (Chlam 98.76
d1w8aa_192 Slit {Fruit fly (Drosophila melanogaster) [TaxId: 98.73
d1w8aa_192 Slit {Fruit fly (Drosophila melanogaster) [TaxId: 98.62
d2ifga3156 High affinity nerve growth factor receptor, N-term 98.25
d2ifga3156 High affinity nerve growth factor receptor, N-term 98.22
d2ca6a1344 Rna1p (RanGAP1), N-terminal domain {Fission yeast 98.01
d2ca6a1344 Rna1p (RanGAP1), N-terminal domain {Fission yeast 97.82
d1koha1162 mRNA export factor tap {Human (Homo sapiens) [TaxI 97.11
d1z7xw1 460 Ribonuclease inhibitor {Human (Homo sapiens) [TaxI 96.17
d1koha1162 mRNA export factor tap {Human (Homo sapiens) [TaxI 95.89
d1z7xw1 460 Ribonuclease inhibitor {Human (Homo sapiens) [TaxI 95.62
d1pgva_167 Tropomodulin C-terminal domain {nematode (Caenorha 95.38
d1io0a_166 Tropomodulin C-terminal domain {Chicken (Gallus ga 95.17
d1pgva_167 Tropomodulin C-terminal domain {nematode (Caenorha 91.61
d1io0a_166 Tropomodulin C-terminal domain {Chicken (Gallus ga 87.01
>d2a5yb3 c.37.1.20 (B:109-385) CED-4, NB-ARC domain {Caenorhabditis elegans [TaxId: 6239]} Back     information, alignment and structure
class: Alpha and beta proteins (a/b)
fold: P-loop containing nucleoside triphosphate hydrolases
superfamily: P-loop containing nucleoside triphosphate hydrolases
family: Extended AAA-ATPase domain
domain: CED-4, NB-ARC domain
species: Caenorhabditis elegans [TaxId: 6239]
Probab=99.65  E-value=2.1e-17  Score=164.48  Aligned_cols=73  Identities=16%  Similarity=0.178  Sum_probs=63.9

Q ss_pred             CccHHHHHHHHHHHhCCChhHHHHHHHHhccCCCHHHHHHHHHHHhcCCCccccCChhhHHHHHHHhHhcCCchhHHHHH
Q 041114          196 HHDILELAQTVTKECGGSPLALITIGRAMAYKKKPEEWRYAIEVLRKSSSSEFAGLVKEVYPLLKFSYDSLQNDVIRSCF  275 (680)
Q Consensus       196 ~~~l~~~~~~I~~kc~GlPLai~~lg~~L~~k~~~~~W~~~l~~l~~~~~~~~~~~~~~i~~~L~~Sy~~L~~~~lk~cf  275 (680)
                      .+..++++++|+++|+|+||||+++|+.|+. ++.++|.+..+.|++ ...      .++..++.+||++||+ ++|+||
T Consensus       204 ~~~~~~~~~~iv~~c~GlPLAl~~ig~~l~~-k~~~~~~~~~~~L~~-~~~------~~v~~il~~sY~~L~~-~lk~c~  274 (277)
T d2a5yb3         204 GEKEEDVLNKTIELSSGNPATLMMFFKSCEP-KTFEKMAQLNNKLES-RGL------VGVECITPYSYKSLAM-ALQRCV  274 (277)
T ss_dssp             -CHHHHHHHHHHHHHTTCHHHHHHHHTTCCS-SSHHHHHHHHHHHHH-HCS------STTCCCSSSSSSSHHH-HHHHHH
T ss_pred             chhhHHHHHHHHHHhCCCHHHHHHHHHHhcc-CCHHHHHHHHHHHhc-CcH------HHHHHHHHHHHhcccH-HHHHHH
Confidence            4557899999999999999999999999987 789999999988877 322      2688999999999999 999999


Q ss_pred             HH
Q 041114          276 LY  277 (680)
Q Consensus       276 l~  277 (680)
                      -+
T Consensus       275 ~~  276 (277)
T d2a5yb3         275 EV  276 (277)
T ss_dssp             HT
T ss_pred             Hh
Confidence            75



>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Back     information, alignment and structure
>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Back     information, alignment and structure
>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Back     information, alignment and structure
>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Back     information, alignment and structure
>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Back     information, alignment and structure
>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Back     information, alignment and structure
>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Back     information, alignment and structure
>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure